Texas Permanent School Fund Incyte Corp Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$51.18 - $63.75 $394,034 - $490,811	-7,699 Reduced 20.02%	30,753 $1.86 Million
Q1 2024 May 03, 2024	BUY	$56.55 - $66.59 $2,544 - $2,996	45 Added 0.12%	38,452 $2.19 Million
Q4 2023 Feb 08, 2024	SELL	$52.16 - $64.19 $1,356 - $1,668	-26 Reduced 0.07%	38,407 $2.41 Million
Q3 2023 Nov 09, 2023	SELL	$57.77 - $65.93 $22,876 - $26,108	-396 Reduced 1.02%	38,433 $2.22 Million
Q2 2023 Aug 07, 2023	BUY	$60.95 - $75.51 $15,054 - $18,650	247 Added 0.64%	38,829 $2.42 Million
Q1 2023 May 01, 2023	BUY	$70.23 - $86.01 $867,059 - $1.06 Million	12,346 Added 47.06%	38,582 $2.79 Million
Q4 2022 Feb 07, 2023	BUY	$67.18 - $84.11 $7,658 - $9,588	114 Added 0.44%	26,236 $2.11 Million
Q3 2022 Oct 25, 2022	BUY	$66.18 - $82.86 $82,989 - $103,906	1,254 Added 5.04%	26,122 $1.74 Million
Q2 2022 Aug 08, 2022	BUY	$66.18 - $83.18 $30,839 - $38,761	466 Added 1.91%	24,868 $1.89 Million
Q1 2022 May 06, 2022	SELL	$66.02 - $79.71 $96,257 - $116,217	-1,458 Reduced 5.64%	24,402 $1.94 Million
Q4 2021 Feb 08, 2022	SELL	$63.34 - $74.11 $200,597 - $234,706	-3,167 Reduced 10.91%	25,860 $1.9 Million
Q3 2021 Oct 28, 2021	SELL	$68.67 - $84.02 $139,262 - $170,392	-2,028 Reduced 6.53%	29,027 $2 Million
Q2 2021 Jul 27, 2021	SELL	$79.87 - $87.53 $11,900 - $13,041	-149 Reduced 0.48%	31,055 $2.61 Million
Q1 2021 May 03, 2021	SELL	$76.02 - $100.5 $35,577 - $47,034	-468 Reduced 1.48%	31,204 $2.54 Million
Q4 2020 Feb 04, 2021	SELL	$80.74 - $97.7 $198,943 - $240,732	-2,464 Reduced 7.22%	31,672 $2.76 Million
Q3 2020 Nov 06, 2020	BUY	$85.07 - $109.69 $199,404 - $257,113	2,344 Added 7.37%	34,136 $3.06 Million
Q2 2020 Aug 04, 2020	SELL	$74.18 - $108.93 $49,774 - $73,092	-671 Reduced 2.07%	31,792 $3.31 Million
Q1 2020 Apr 27, 2020	BUY	$63.18 - $85.97 $52,313 - $71,183	828 Added 2.62%	32,463 $2.38 Million
Q4 2019 Feb 03, 2020	SELL	$73.04 - $95.72 $118,032 - $154,683	-1,616 Reduced 4.86%	31,635 $2.76 Million
Q3 2019 Oct 31, 2019	SELL	$72.82 - $86.52 $78,135 - $92,835	-1,073 Reduced 3.13%	33,251 $2.47 Million
Q2 2019 Aug 09, 2019	SELL	$73.52 - $88.7 $17,571 - $21,199	-239 Reduced 0.69%	34,324 $2.92 Million
Q1 2019 May 02, 2019	SELL	$63.56 - $88.17 $61,271 - $84,995	-964 Reduced 2.71%	34,563 $2.97 Million
Q4 2018 Feb 11, 2019	SELL	$58.5 - $69.94 $238,797 - $285,495	-4,082 Reduced 10.31%	35,527 $2.26 Million
Q3 2018 Oct 22, 2018	SELL	$61.75 - $74.23 $205,257 - $246,740	-3,324 Reduced 7.74%	39,609 $2.74 Million
Q2 2018 Jul 23, 2018	SELL	$60.85 - $83.98 $149,691 - $206,590	-2,460 Reduced 5.42%	42,933 $2.88 Million
Q1 2018 Apr 20, 2018	SELL	$83.06 - $100.98 $201,420 - $244,876	-2,425 Reduced 5.07%	45,393 $3.78 Million
Q4 2017 Jan 23, 2018	BUY	$93.56 - $116.6 $46,967 - $58,533	502 Added 1.06%	47,818 $4.53 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $5.16 Million - $6.54 Million	47,316	47,316 $5.52 Million

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account